Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion

Summary

Effects of ischaemic preconditioning (IP) on the mobilisation and recruitment of haematopoietic (HSCs) and mesenchymal stem (MSC) cells were determined in porcine coronary occlusion/reperfusion. Thirtythree pigs underwent percutaneous occlusion of the left anterior descending coronary artery (LAD) for 90 minutes (min), followed by 120 min reperfusion. IP was performed in 16 of the 33 pigs by two cycles of 5 min balloon occlusion/reperfusion prior to the 90 min occlusion (group IP vs. group C). Peripheral blood and myocardial tissue concentration of bone marrow origin HSCs (characterised by coexpression of CD31+, CD90+, CD45+) and MSCs (characterised by coexpression of CD44+, CD90+, CD45-) were measured by flow cytometry in the early phase of IP. Plasma/serum levels of stem cell mobilisation factors (stromal cell-derived factor-1α [SDF-1α], vascular endothelial growth factor [VEGF], tumour necrosis factor α[TNF-α] and interleukin-8 [IL-8]) were measured. IP led to a significant increase in circulating HSCs as compared with the group C (475 ± 233 vs. 281 ± 264 /μl, p=0.032) in the early phase of IP. In contrast, a rapid and prolonged decrease in level of circulating MSCs was observed in group IP as compared with group C (19 ± 12 vs. 32 ± 17 /μl, p=0.015). The recruitment of HSCs and MSCs in infarct and border zone was significantly greater in IP group, indicating a faster homing of MSCs as compared with the rate of mobilisation. Rapid increase in VEGF, TNF-α and IL-8 levels was induced by IP, which, however, was not correlated with the levels of circulating SCs. In conclusion, IP resulted in differential mobilisation and recruitment of HSCs and MSCs in the early phase of cardioprotection.

Keywords

Stem cell mobilisation - haematopoietic - mesenchymal - stromal-derived - ischaemic preconditioning

• References

• 1 Massa M, Rosti V, Ferrario M. et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005; 105: 199-206.
• 2 Wojakowski W, Tendera M, Michalowska A. et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+, stem cells, and mononuclear cells expressing early cardiac, muscle and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004; 110: 3213-3220.
• 3 Leone AM, Rutella S, Bonanno G. et al. Mobilisation of bone marrow derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005; 26: 1196-1204.
• 4 Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005; 45: 321-325.
• 5 Murray CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
• 6 Tomai F, Crea F, Chiariello L. et al. Ischemic preconditioning in humans – models, mediators, and clinical relevance. Circulation 1999; 100: 559-563.
• 7 Gurke L, Marx A, Sutter PM. et al. Ischemic preconditioning improves postischemic skeletal muscle function. Am Surg 1996; 62: 391-394.
• 8 Xu M, Wang Y, Ayub A. et al. Mitochondrial K(ATP) channel activation reduces anoxic injury by restoring mitochondrial membrane potential. Am J Physiol Heart Circ Physiol 2001; 281: H1295-1303.
• 9 Takashi E, Ashraf M. Pathologic assessment of myocardial cell necrosis and apoptosis after ischemia and reperfusion with molecular and morphological markers. J Mol Cell Cardiol 2000; 32: 209-224.
• 10 Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 2006; 70: 240-253.
• 11 Li M, Nishimura H, Iwakura A. et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via “imported” nitric oxide synthase activity. Circulation 2005; 111: 1114-1120.
• 12 Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 2006; 34: 967-975.
• 13 Heeschen C, Lehmann R, Honold J. et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004; 109: 1615-1622.
• 14 Hu X, Dai S, Wu WJ. et al. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation. 2007; 116: 654-663.
• 15 Neuss S, Becher E, Wöltje M. et al. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair and wound healing. Stem Cells 2004; 22: 405-414.
• 16 Haider HKh, Ashraf M. Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 2008; 45: 554-566.
• 17 Leshnower BG, Sakamoto H, Zeeshan A. et al. Role of acetaminophen in acute myocardial infarction. Am J Physiol Heart Circ Physiol 2006; 290: H2424-2431.
• 18 Vasa M, Fichtlscherer S, Aicher A. et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: e1-e7.
• 19 Li TS, Suzuki R, Ueda K. et al. Analysis of the origin and population dynamics of cardiac progenitor cells in a donor heart model. Stem Cells 2007; 25: 911-917.
• 20 Bosch P, Pratt SL, Stice SL. Isolation, characterization, gene modification and nuclear reprogramming of porcine mesenchymal stem cells. Biol Repr 2006; 74: 46-57.
• 21 Konhilas JP, Irving TC, Wolska BM. et al. Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing. J Physiol 2003; 547: 951-961.
• 22 Kamota T, Li TS, Morikage N. et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol 2009; 53: 1814-1822.
• 23 Wang Y, Johnsen HE, Mortensen S. et al. Changes in cirulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 2006; 92: 768-774.
• 24 Pitchford SC, Furze RC, Jones CP. et al. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell. 2009; 04: 62-72.
• 25 Ip JE, Wu Y, Huang J et al. Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell 2007; 18: 2873-2882.
• 26 Ho IAW, Chan KYW, Ng WH. et al. Matrix Metalloproteinase 1 Is Necessary for the Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Human Glioma. Stem Cells 2009; 27: 1366-1375.
• 27 Beckermann BM, Kallifatidis G, Groth A. et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. British J Cancer 2008; 99: 622-631.
• 28 Penn MS. Importance of the SDF-1:CXCR4 Axis in Myocardial Repair. Circ Res 2009; 104: 1133-1135.
• 29 Askari A, Unzek S, Popovic ZB. et al. Effect of stromal-cell-derived factor-1 on stem cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet 2003; 362: 697-703.
• 30 Menasche P. Stem cells for clinical use in cardiovascular medicine. Thromb Haemost 2005; 94: 697-701.
• 31 Özüyaman B, Ebner P, Niesler U. et al. Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost 2005; 94: 770-772.
• 32 Cottler-Fox MH, Lapidot T, Petit I. et al. Stem cell mobilization. Hematology 2003; 04: 19-37.
• 33 Kim YS, Park HJ, Hong MH. et al. TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium. Front Biosci 2009; 14: 2845-2856.
• 34 Ponte AL, Marais E, Gallay N. et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007; 25: 1737-1745.
• 35 Das DK, Maulik N. Cardiac genomic response following preconditioning stimulus. Cardiovasc Res 2006; 70: 254-263.
• 36 Lecour S, Rochette L, Opie LH. Free radicals trigger TNF alpha-induced cardioprotection. Cardiovasc Res 2005; 65: 239-243.